Monthly Archives: December 2024

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

Posted on December 19, 2024 by steve@pepromenebio.com

To find the article on the web: PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma   IRVINE, Calif., Dec. 19, 2024 /PRNewswire/ — PeproMene Bio, Inc. (PMB) … Continue reading →

Posted in 2024 | Leave a comment